Search for a command to run...
Henry Schein, Inc.
Medical Distribution
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Jun 25, 2026 |  Michael T. McCaulR | Stock | Sell |
| $15,001 - $50,000 |
| $83.69 |
| $85.47 |
| +2.1% |
| +1.5% |
May 15, 2026 |  Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $72.72 | $81.25 | +11.7% | +11.4% |
Mar 30, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $72.70 | $73.80 | +1.5% | -11.1% |
Jan 29, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $74.34 | $82.39 | +10.8% | +12.0% |
Jan 9, 2026 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $77.64 | $79.72 | +2.7% | +3.2% |
Aug 21, 2025 | Michael T. McCaulR | Stock | Sell | $1,001 - $15,000 | $68.21 | $67.86 | -0.5% | -5.2% |
Apr 15, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $64.28 | $71.54 | +11.3% | +1.5% |
Apr 8, 2025 |  Rob BresnahanR | Stock | Buy | $1,001 - $15,000 | $62.70 | $68.89 | +9.9% | -3.9% |
Apr 1, 2025 |  Julie JohnsonD | Stock | Sell | $1,001 - $15,000 | $69.07 | $64.46 | -6.7% | -6.2% |
Mar 31, 2025 |  Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $68.49 | $64.97 | -5.1% | -4.3% |
Mar 6, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $72.96 | $65.47 | -10.3% | +1.2% |
Jan 17, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $73.22 | $76.00 | +3.8% | +1.8% |
Dec 20, 2024 | Michael T. McCaulR | Stock | Sell | $1,001 - $15,000 | $69.82 | $73.22 | +4.9% | +3.8% |
Dec 20, 2024 | Michael T. McCaulR | Stock | Sell | $1,001 - $15,000 | $69.82 | $73.22 | +4.9% | +3.8% |
Dec 10, 2024 | Michael T. McCaulR | Stock | Buy | $1,001 - $15,000 | $74.73 | $71.06 | -4.9% | -3.0% |
Dec 10, 2024 | Michael T. McCaulR | Stock | Buy | $1,001 - $15,000 | $74.73 | $71.06 | -4.9% | -3.0% |
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
3 Reasons to Avoid HSIC and 1 Stock to Buy Instead
Is Henry Schein Stock Underperforming the Nasdaq?
Henry Schein: Smile Because The Upside Isn't Over
3 Unpopular Stocks We Approach with Caution